$PSTI breakout $3.37 Website

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone
$PSTI breakout $3.37

Website
logoemp.png

88 % Buy
detailed opinion
850318709_barchart_logo1.jpg

Shares Outstanding5: 70.08M
Float: 65.73M

% Held by Insiders: 8.61%
% Held by Institutions: 1.50%
Shares Short (as of Dec 31, 2014): 503.53K
Short Ratio (as of Dec 31, 2014): 3.40
Short % of Float (as of Dec 31, 2014): 0.80%
Shares Short (prior month)3: 386.70K

yahoo_finance_en-US_s_f_p_191x21_finance_2x.png


10-Q 11/6/14

Summary

Recent trades
599675067_stockwatch.jpg


Headlines


Tuesday, January 27, 2015
Updated Coverage Report Focuses on Pluristem TherapeuticsMarketwired (Tue, Jan 27)

Tuesday, January 13, 2015
Pluristem to Present at Two Cell Therapy Conferences in January 2015GlobeNewswire (Tue, Jan 13)

Monday, January 12, 2015
PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Pluristem Issues Letter to ShareholdersGlobeNewswire (Mon, Jan 12)

Tuesday, January 6, 2015
Pluristem Granted Patent for Foundational Cell Harvesting Technology in South AfricaGlobeNewswire (Tue, Jan 6)

Monday, December 22, 2014
New Published Data Show Pluristem's PLX Cells Protect NeuronsGlobeNewswire (Mon, Dec 22)

Thursday, December 4, 2014
Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant OutcomesGlobeNewswire (Thu, Dec 4)

Monday, December 1, 2014
Pluristem Granted Patent in Singapore for Its 3D Cell Expansion TechnologyGlobeNewswire (Mon, Dec 1)

Tuesday, November 25, 2014
Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific ConferencesGlobeNewswire (Tue, Nov 25)

Friday, November 21, 2014
Pluristem posts 1Q lossAP (Fri, Nov 21)

Tuesday, November 18, 2014
PLURISTEM THERAPEUTICS INC FinancialsEDGAR Online Financials (Tue, Nov 18)

Wednesday, November 12, 2014
Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple IndicationsGlobeNewswire (Wed, Nov 12)

Monday, November 10, 2014
Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014GlobeNewswire (Mon, Nov 10)

Thursday, November 6, 2014
PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 6)

Monday, October 27, 2014
The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4%Zacks (Mon, Oct 27)

Tuesday, October 14, 2014
Dynavax Initiates Phase I/II Trial on Lymphoma CandidateZacks (Tue, Oct 14)

Wednesday, October 8, 2014
Can the Uptrend Continue for Pluristem (PSTI)?Zacks (Wed, Oct 8)

Tuesday, October 7, 2014
Sunesis Pharmaceuticals Down on Failure of Trial on QinprezoZacks (Tue, Oct 7)
Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.5%Zacks (Tue, Oct 7)

Monday, October 6, 2014
Incyte Receives $60M Milestone Payment Related to JakaviZacks (Mon, Oct 6)

Pluri Inc. (PLUR) Stock Research Links

PLUR Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 247

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Aalberts Shares Buyback Program Updates and Insights

Updated Category News Views 113

Overview of Aalberts' Share Buyback Program Aalberts has recently announced the progress of its ongoing share buyback program, giving investors and shareholders a detailed look into its current operations. This program is part of a strategic initiative to enhance shareholder value and demonstrate confidence in the company's long-term prospects. Recent Share Repurchase...

Continue Reading
American Water Named Among 2025 Most Responsible Companies

Updated Category News Views 206

American Water's Recognition on Newsweek’s List American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., is proud to announce its inclusion in Newsweek’s list of America’s Most Responsible Companies for 2025. This honor reflects American Water's unwavering commitment to environmental, social, and governance (ESG)...

Continue Reading
Pendulum Ink Reimagines Hip-Hop Education with New Model

Updated Category News Views 289

Pendulum Ink Innovates Online Hip-Hop Education Pendulum Ink, recognized as the world's first online hip-hop academy, has made headlines with its recent relaunch featuring a subscription-based model. This new structure is designed to provide flexible engagement tiers, making hip-hop education accessible to learners around the globe. The relaunch not only aims to educate...

Continue Reading
Revolutionizing Radiology: Mach7 Technologies Launches UnityVue

Updated Category News Views 90

Mach7 Technologies Introduces UnityVue for Radiology Mach7 Technologies is thrilled to announce the release of UnityVue, an advanced, AI-driven workflow orchestration solution designed to enhance patient care, alleviate radiologist burnout, and optimize diagnostic workflows. This innovative platform aims to create a more efficient radiology environment, making it a...

Continue Reading
Purina Partners with UC Davis to Enhance Pet Urinary Health

Updated Category News Views 150

Purina Teams Up with UC Davis School of Veterinary Medicine Nestlé Purina PetCare is thrilled to share a groundbreaking partnership with the University of California, Davis. This collaboration is focused on improving our understanding of urinary health in pets. With the support of a generous grant, this initiative represents a major step forward in scientific research...

Continue Reading